Scientists have developed a new test to detect signs of Alzheimer’s disease based on markers in a blood sample, an advance that may lead to better risk prediction for the neurological condition.
Currently, diagnosing Alzheimer’s disease requires “expensive” and time-consuming neuroimaging tests, say researchers, including those from the University of Pittsburgh in the US.
